FMR LLC 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-12 08:21 am Sale | 2023-06-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 20,082 0.115% | -869,119 (-97.74%) | Filing |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 889,201 5.144% | -659,458 (-42.58%) | Filing |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 1,548,659 8.960% | -908,501 (-36.97%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 2,457,159 14.368% | 365,849 (+17.49%) | Filing |
| 2021-02-08 10:31 am Sale | 2021-02-05 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 2,091,310 12.375% | -192,796 (-8.44%) | Filing |